CRB-701 / Corbus Pharma, CSPC Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CRB-701 / CSPC Pharma, Corbus Pharma
CRB-701-01, NCT06265727: A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Recruiting
1/2
420
Europe, US, RoW
CRB-701
Corbus Pharmaceuticals Inc., CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Solid Tumor, Adult
01/27
01/27

Download Options